149 related articles for article (PubMed ID: 32848734)
1. AKT Inhibitor SC66 Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Through Down-Regulating AKT/β-Catenin Pathway.
Gao L; Liu J; Xu P; Deng G; Liu B; Yuan F; Tan Y; Sun Q; Xu Y; Zhang H; Qi Y; Han S; Yang K; Geng R; Jiang H; Chen Q
Front Pharmacol; 2020; 11():1102. PubMed ID: 32848734
[TBL] [Abstract][Full Text] [Related]
2. SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β-catenin pathway.
Chen W; Zhao S; Yu W; Rao T; Ruan Y; Zhu S; Xia Y; Song H; Cheng F
J Cell Mol Med; 2021 Nov; 25(22):10684-10697. PubMed ID: 34687144
[TBL] [Abstract][Full Text] [Related]
3. The New PI3K/mTOR Inhibitor GNE-477 Inhibits the Malignant Behavior of Human Glioblastoma Cells.
Wang Y; Shen H; Sun Q; Zhao L; Liu H; Ye L; Xu Y; Cai J; Li Y; Gao L; Tan Y; Liu B; Chen Q
Front Pharmacol; 2021; 12():659511. PubMed ID: 34381355
[TBL] [Abstract][Full Text] [Related]
4. The critical role of EGF-β-catenin signaling in the epithelial-mesenchymal transition in human glioblastoma.
Wang X; Wang S; Li X; Jin S; Xiong F; Wang X
Onco Targets Ther; 2017; 10():2781-2789. PubMed ID: 28615958
[TBL] [Abstract][Full Text] [Related]
5. GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/β-catenin signaling pathway.
Ding X; Deng G; Liu J; Liu B; Yuan F; Yang X; Chen Q
Brain Res; 2019 Aug; 1717():117-126. PubMed ID: 30935831
[TBL] [Abstract][Full Text] [Related]
6. Targeting Akt by SC66 triggers GSK-3β mediated apoptosis in colon cancer therapy.
Liu Y; Huang Y; Ding J; Liu N; Peng S; Wang J; Wang F; Zhang Y
Cancer Cell Int; 2019; 19():124. PubMed ID: 31168297
[TBL] [Abstract][Full Text] [Related]
7. Quercetin induces MGMT
Wang W; Yuan X; Mu J; Zou Y; Xu L; Chen J; Zhu X; Li B; Zeng Z; Wu X; Yin Z; Wang Q
Phytomedicine; 2023 Sep; 118():154933. PubMed ID: 37451151
[TBL] [Abstract][Full Text] [Related]
8. Raddeanin A inhibited epithelial-mesenchymal transition (EMT) and angiogenesis in glioblastoma by downregulating β-catenin expression.
Wu B; Zhu J; Dai X; Ye L; Wang B; Cheng H; Wang W
Int J Med Sci; 2021; 18(7):1609-1617. PubMed ID: 33746577
[TBL] [Abstract][Full Text] [Related]
9. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
10. Demethoxycurcumin Suppresses Proliferation, Migration, and Invasion of Human Brain Glioblastoma Multiforme GBM 8401 Cells
Su RY; Hsueh SC; Chen CY; Hsu MJ; Lu HF; Peng SF; Chen PY; Lien JC; Chen YL; Chueh FS; Chung JG; Yeh MY; Huang YP
Anticancer Res; 2021 Apr; 41(4):1859-1870. PubMed ID: 33813391
[TBL] [Abstract][Full Text] [Related]
11. Akt inhibitor SC66 promotes cell sensitivity to cisplatin in chemoresistant ovarian cancer cells through inhibition of COL11A1 expression.
Wu YH; Huang YF; Chen CC; Chou CY
Cell Death Dis; 2019 Apr; 10(4):322. PubMed ID: 30975980
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic value of SC66 in human renal cell carcinoma cells.
Xu M; Wang Y; Zhou LN; Xu LJ; Jin ZC; Yang DR; Chen MB; Zhu J
Cell Death Dis; 2020 May; 11(5):353. PubMed ID: 32393791
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of autophagy can promote the apoptosis of bladder cancer cells induced by SC66 through the endoplasmic reticulum stress pathway.
Wang L; Song R; Ma M; Chen Y; Jiang Y; Li J; Yang Z; Zhang L; Jing M; Wang X; Zhang M; Fan J
Chem Biol Interact; 2023 Oct; 384():110725. PubMed ID: 37741534
[TBL] [Abstract][Full Text] [Related]
14. Verbascoside inhibits progression of glioblastoma cells by promoting Let-7g-5p and down-regulating HMGA2 via Wnt/beta-catenin signalling blockade.
Jia WQ; Zhu JW; Yang CY; Ma J; Pu TY; Han GQ; Zou MM; Xu RX
J Cell Mol Med; 2020 Mar; 24(5):2901-2916. PubMed ID: 32000296
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of FAM83D displays antitumor effects in glioblastoma via down-regulation of the AKT/Wnt/β-catenin pathway.
Wang J; Quan Y; Lv J; Gong S; Ren P
Environ Toxicol; 2022 Jun; 37(6):1343-1356. PubMed ID: 35150198
[TBL] [Abstract][Full Text] [Related]
16. CCL2-targeted ginkgolic acid exerts anti-glioblastoma effects by inhibiting the JAK3-STAT1/PI3K-AKT signaling pathway.
Chen X; Zhu M; Zou X; Mao Y; Niu J; Jiang J; Dong T; Shi Y; Yang X; Liu P
Life Sci; 2022 Dec; 311(Pt B):121174. PubMed ID: 36396110
[TBL] [Abstract][Full Text] [Related]
17. 2,5-Dimethyl Celecoxib Inhibits Proliferation and Cell Cycle and Induces Apoptosis in Glioblastoma by Suppressing CIP2A/PP2A/Akt Signaling Axis.
Gao D; Nyalali AMK; Hou Y; Xu Y; Zhou J; Zhao W; Huang B; Li F
J Mol Neurosci; 2021 Aug; 71(8):1703-1713. PubMed ID: 33400072
[TBL] [Abstract][Full Text] [Related]
18. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
[TBL] [Abstract][Full Text] [Related]
19. 3BDO inhibits the proliferation, epithelial-mesenchymal transition (EMT), and stemness via suppressing survivin in human glioblastoma cells.
Wang Z; Li Y; Liu M; Chen D; Lu J; Ji Y; Xing Z; Wang Y
J Cancer; 2022; 13(4):1203-1213. PubMed ID: 35281871
[No Abstract] [Full Text] [Related]
20. Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and β-catenin.
Wang K; Park JO; Zhang M
J Gene Med; 2013 Jan; 15(1):42-50. PubMed ID: 23319157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
